| ASSET | QUARTER | % RETURN |
|---|---|---|
Lifevantage (LFVN) | Q2 2001 | 350% |
Portage Biotech (PRTG) | Q2 2001 | 328.57% |
Xcel Brands (XELB) | Q2 2001 | 304% |
Pixelworks (PXLW) | Q2 2001 | 244.48% |
Booking (BKNG) | Q2 2001 | 229.09% |
F5 Networks (FFIV) | Q2 2001 | 208.92% |
Intuitive Surgical (ISRG) | Q2 2001 | 198.13% |
Inotiv (NOTV) | Q2 2001 | 195.25% |
Universal Insurance (UVE) | Q2 2001 | 183.33% |
Natural Health Trend (NHTC) | Q2 2001 | 169.23% |
Light & Wonder (LNW) | Q2 2001 | 167.73% |
Microbot Medical (MBOT) | Q2 2001 | 164.98% |
Achieve Life Sciences (ACHV) | Q2 2001 | 156.81% |
Manhattan Associates (MANH) | Q2 2001 | 153.38% |
Caesars Entertainment (CZR) | Q2 2001 | 151.16% |
Oblong (OBLG) | Q2 2001 | 146.86% |
Sonic Automotive (SAH) | Q2 2001 | 144.87% |
Acacia Research (ACTG) | Q2 2001 | 143.46% |
Option Care Health (OPCH) | Q2 2001 | 140% |
Sarepta Therapeutics (SRPT) | Q2 2001 | 136.99% |
Group 1 Automotive (GPI) | Q2 2001 | 136.8% |
XOMA (XOMA) | Q2 2001 | 135.31% |
Protalix Biotherapeutics (PLX) | Q2 2001 | 133.33% |
Exelixis (EXEL) | Q2 2001 | 131.69% |
Qorvo (QRVO) | Q2 2001 | 130.76% |
